Vol 13, No 4 (August 31, 2022) - Journal of Gastrointestinal Oncology

Original Article

Whole-process nursing management for laparo-gastroscopic esophagectomy

Zhe Wang, Minxuan Wu, Hui Zhao, Lina Cao, Yufeng Ou, Ping Wang, Lingli Yang, Li Dong, Yiqun Zhang, Yaxing Shen

Journal of Gastrointestinal Oncology

2022;

(4)

:1516-1524

(31 August 2022)

PDF Full Text (3085) Reporting Checklist Data Sharing Statement COI Form Open Access

Systematic review and meta-analysis of endoscopic ultrasonography in staging diagnosis of esophageal cancer after neoadjuvant radiotherapy and chemotherapy

Xiaodong Li, Yixiao Wang, Min Kong, Jiang Lin

Journal of Gastrointestinal Oncology

2022;

(4)

:1525-1540

(31 August 2022)

PDF Full Text (1462) Reporting Checklist COI Form Open Access

MiR-107 inhibits the malignant biological behavior of esophageal squamous cell carcinoma by targeting TPM3

Peipei Zhang, Weiguang Zhang, Junfei Jiang, Zhimin Shen, Sui Chen, Shaobin Yu, Mingqiang Kang

Journal of Gastrointestinal Oncology

2022;

(4)

:1541-1555

(31 August 2022)

PDF Full Text (1709) Reporting Checklist Data Sharing Statement COI Form Open Access

The prognostic value of an immune-related gene signature and infiltrating tumor immune cells based on bioinformatics analysis in primary esophageal cancer

Hailei Du, Shuai Pang, Yong Li, Lianggang Zhu, Junbiao Hang, Ling Chen

Journal of Gastrointestinal Oncology

2022;

(4)

:1556-1570

(31 August 2022)

PDF Full Text (2209) Reporting Checklist COI Form Open Access

Interleukin 13 participates in terminal differentiation of esophageal squamous cell carcinoma cells

Jian Li, Wenjian Wang, Ke Wang, Guangwei Ma, Jing Shao, Weizhen Fang, Yiting Zhou, Jiatong Lin, Yabin Guo, Xinyuan Guan, Chaohui Duan

Journal of Gastrointestinal Oncology

2022;

(4)

:1571-1578

(31 August 2022)

PDF Full Text (1754) Reporting Checklist Data Sharing Statement COI Form Open Access

Modified McKeown vs. traditional McKeown minimally invasive esophagectomy in improving short-term efficacy and the quality of life of esophageal cancers: a retrospective comparative cohort study

Ying Chen, Yujie Xie, Hai Zhang, Zuwei Li, Bomeng Wu, Cui Li, Wanli Lin

Journal of Gastrointestinal Oncology

2022;

(4)

:1579-1588

(31 August 2022)

PDF Full Text (1878) Reporting Checklist Data Sharing Statement COI Form Open Access

Bioinformatics analysis of the prognostic and immunotherapeutic significance of NPRL2 in stomach adenocarcinoma

Yilin Pi, Yuning Zhan, Jitao Song, Xin Jin, Jing Chen

Journal of Gastrointestinal Oncology

2022;

(4)

:1589-1604

(31 August 2022)

PDF Full Text (1993) Reporting Checklist COI Form Open Access

Lymph node metastases rate of locoregional and non-locoregional lymph node stations in gastric cancer

Mees Hendrik Siert de Jong, Suzanne Sarah Gisbertz, Mark Ivo van Berge Henegouwen, Werner Adriaan Draaisma

Journal of Gastrointestinal Oncology

2022;

(4)

:1605-1615

(31 August 2022)

PDF Full Text (2238) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Analysis of safety and efficacy of laparoscopic radical gastrectomy combined with or without indocyanine green tracer fluorescence technique in treatment of gastric cancer: a retrospective cohort study

Xiaoning Chen, Zhengwei Zhang, Feng Zhang, Xuanchen Tao, Xu Zhang, Zeyu Sun, Shibo Sun

Journal of Gastrointestinal Oncology

2022;

(4)

:1616-1625

(31 August 2022)

PDF Full Text (1755) Reporting Checklist Data Sharing Statement COI Form Open Access

Circ_0007099 upregulates GNG7 to function as a tumor inhibitor in gastric carcinoma by interacting with miR-425-3p

Zhipeng Zhang, Yikai Zhou, Na Zhou, Junda Yin, Xuechun Kuang

Journal of Gastrointestinal Oncology

2022;

(4)

:1626-1639

(31 August 2022)

PDF Full Text (1693) Reporting Checklist Data Sharing Statement COI Form Open Access

Construction and validation of a novel prognostic model using the cellular senescence-associated long non-coding RNA in gastric cancer: a biological analysis

Guoqing Wang, Zhilei Mao, Xiao Zhou, Yiming Zou, Min Zhao

Journal of Gastrointestinal Oncology

2022;

(4)

:1640-1655

(31 August 2022)

PDF Full Text (1664) Reporting Checklist COI Form Open Access

Identification of 8-gene risk prediction signature associated with NOTCH1 in stomach adenocarcinoma based on bioinformatics analysis

Dun Pan, Chun Lin, Xin Lin, Liangqing Li

Journal of Gastrointestinal Oncology

2022;

(4)

:1656-1667

(31 August 2022)

PDF Full Text (1615) Reporting Checklist COI Form Open Access

Intratumoral CD8⁺ T cells as a potential positive predictor of chemoimmunotherapy response in PD-L1-negative advanced gastric cancer patients: a retrospective cohort study

Gangling Tong, Meiqin Zhu, Yaoxu Chen, Shubo Wang, Boran Cheng, Shubin Wang, Wangjun Liao

Journal of Gastrointestinal Oncology

2022;

(4)

:1668-1678

(31 August 2022)

PDF Full Text (2267) Reporting Checklist Data Sharing Statement COI Form Open Access

Safety and effectiveness of apatinib in elderly patients with metastatic gastric cancer: a sub-analysis from the large-scale, prospective observational study of apatinib for gastric cancer treatment in a real-world clinical setting (AHEAD-G202)

Xiang Wang, Diansheng Zhong, Junping Zhang, Nan Du, Yuchuan Ren, Jinghua Gao, Likun Liu, Junyan Yu, Xiaomei Li, Liwen Ma, Aimin Zang, Mudan Yang, Yan Zhang, Jun Guo, Zheng Liu, Zhanzhao Fu, Junmei Jia, Jianfeng Diao, Zaiwen Fan, Xiang Song, Guozhong Li, Huaqing Wang, Chunmei Bai, Mei Guan, Xiubao Ren, Ruixing Zhang

Journal of Gastrointestinal Oncology

2022;

(4)

:1679-1689

(31 August 2022)

PDF Full Text (1571) Reporting Checklist Data Sharing Statement COI Form Open Access

Identification of candidate biomarkers associated with gastric cancer prognosis based on an integrated bioinformatics analysis

Yong Liu, Da-Xiu Wang, Xiao-Jing Wan, Xian-Hong Meng

Journal of Gastrointestinal Oncology

2022;

(4)

:1690-1700

(31 August 2022)

PDF Full Text (1894) Reporting Checklist COI Form Open Access

A post-marketing safety study of ramucirumab with FOLFIRI in patients with metastatic colorectal cancer

Toshiki Masuishi, Soshi Nagaoka, Long Jin, Kenichi Yoshizawa

Journal of Gastrointestinal Oncology

2022;

(4)

:1701-1710

(31 August 2022)

PDF Full Text (2932) Reporting Checklist Data Sharing Statement COI Form Open Access

Validation of a genotype-based algorithm that identifies individuals with low, intermediate, and high serum CA19-9 levels in cancer-free individuals and in patients with colorectal cancer

Andreas Wannhoff, Simone Werner, Sha Tao, Hermann Brenner, Daniel N. Gotthardt

Journal of Gastrointestinal Oncology

2022;

(4)

:1711-1721

(31 August 2022)

PDF Full Text (1837) Reporting Checklist Data Sharing Statement COI Form Open Access

Luteolin suppresses the growth of colon cancer cells by inhibiting the IL-6/STAT3 signaling pathway

Jingwen Jiang, Fengting Zhu, Hui Zhang, Tao Sun, Fangfang Fu, Xuewu Chen, Yanhong Zhang

Journal of Gastrointestinal Oncology

2022;

(4)

:1722-1732

(31 August 2022)

PDF Full Text (2514) Reporting Checklist Data Sharing Statement COI Form Open Access

Surgical treatment and survival analysis of primary duodenal malignant tumor: a retrospective cohort study

Zhicheng Zhao, Jiehong Zhang, Chuan Li, Tong Liu, Weidong Li

Journal of Gastrointestinal Oncology

2022;

(4)

:1733-1745

(31 August 2022)

PDF Full Text (1763) Reporting Checklist Data Sharing Statement COI Form Open Access

Lymphadenectomy with venation is preferred compared to skeletonization for patients with rectal and sigmoid colon cancer: a retrospective cohort study

Wei Ge, Hai-Yan Gong, Li-Hua Shao, Gang Chen, Yu-Dong Qiu

Journal of Gastrointestinal Oncology

2022;

(4)

:1746-1752

(31 August 2022)

PDF Full Text (1342) Reporting Checklist Data Sharing Statement COI Form Open Access

High levels of triglycerides, apolipoprotein B, and the number of colorectal polyps are risk factors for colorectal polyp recurrence after endoscopic resection: a retrospective study

Jia-Yu Du, Gui-Ying Huang, Yong-Chun Xie, Nan-Xi Li, Zhi-Wei Lin, Li Zhang

Journal of Gastrointestinal Oncology

2022;

(4)

:1753-1760

(31 August 2022)

PDF Full Text (2253) Reporting Checklist Data Sharing Statement COI Form Open Access

Low CPEB1 levels may predict the benefit of 5-fluorouracil treatment in patients with colon or stomach adenocarcinoma

Jing-Zhu Cao, Dan-Dan Niu, Zhi-Ping Huang, Yong-Gang Hong, Zhen-Guang Wang, Le Yang, Bo-Lun Zhao, Guang-Lei Qiao, Liu Ouyang

Journal of Gastrointestinal Oncology

2022;

(4)

:1761-1771

(31 August 2022)

PDF Full Text (1829) Reporting Checklist Data Sharing Statement COI Form Open Access

The prognostic role of neutrophil-to-lymphocyte ratio and C-reactive protein in metastatic colorectal cancer using regorafenib: a systematic review and meta-analysis

Nan Zhao, Huilin Xu, Dingjie Zhou, Ximing Xu, Wei Ge, Dedong Cao

Journal of Gastrointestinal Oncology

2022;

(4)

:1772-1781

(31 August 2022)

PDF Full Text (2020) Reporting Checklist COI Form Open Access

Diagnostic and prognostic potential of the novel biomarker nuclear cap binding protein subunit 2 (NCBP2) in colon adenocarcinoma

He Bu, Ting Cao, Xuesong Li, Yuekun Guo, Jiajia Guo, Yuxin Wang, Yunlong Sun, Donghong Wang

Journal of Gastrointestinal Oncology

2022;

(4)

:1782-1792

(31 August 2022)

PDF Full Text (2060) Reporting Checklist Data Sharing Statement COI Form Open Access

Circular RNA ZFR promotes cell cycle arrest and apoptosis of colorectal cancer cells via the miR-147a/CACUL1 axis

Yuhan Tan, Kai Wang, Ying Kong

Journal of Gastrointestinal Oncology

2022;

(4)

:1793-1804

(31 August 2022)

PDF Full Text (1614) Reporting Checklist Data Sharing Statement COI Form Open Access

Association of sleep duration, sleep apnea, and shift work with risk of colorectal neoplasms: a systematic review and meta-analysis

Gang Wang, Jian-Jiang Wang, Chao-Huang Lin, Qing Zhou, Wei-Long Wang, Tao Qin, Xin Li, Ze-Jun Wang

Journal of Gastrointestinal Oncology

2022;

(4)

:1805-1817

(31 August 2022)

PDF Full Text (2234) Reporting Checklist COI Form Open Access

Transcecum catheterization ileostomy is safe and effective to prevent anastomotic leakage in post-laparoscopic rectal cancer surgery: a single-center retrospective study

Hao Sun, Yongpeng He, Xiaohua Li, Zhixiong Chen, Maocai Tang, Jingkun Shang, Wang Huang, Shuaiqi Wang

Journal of Gastrointestinal Oncology

2022;

(4)

:1818-1831

(31 August 2022)

PDF Full Text (1400) Reporting Checklist Data Sharing Statement COI Form Open Access

Chemoprotective effect of boeravinone B against 1,2-dimethyl hydrazine induced colorectal cancer in rats via suppression of oxidative stress and inflammatory reaction

Caijin Zhou, Wenting Ou, Qingwen Xu, Lin Lin, Feipeng Xu, Rihong Chen, Huilai Miao

Journal of Gastrointestinal Oncology

2022;

(4)

:1832-1841

(31 August 2022)

PDF Full Text (2375) Reporting Checklist Data Sharing Statement COI Form Open Access

A novel senescence-associated LncRNA signature predicts the prognosis and tumor microenvironment of patients with colorectal cancer: a bioinformatics analysis

Enmin Huang, Tao Ma, Junyi Zhou, Ning Ma, Weisheng Yang, Chuangxiong Liu, Zehui Hou, Shuang Chen, Zhen Zong, Bing Zeng, Yingru Li, Taicheng Zhou

Journal of Gastrointestinal Oncology

2022;

(4)

:1842-1863

(31 August 2022)

PDF Full Text (3039) Reporting Checklist Data Sharing Statement COI Form Open Access

Characterization of somatic mutations and pathway alterations during hepatocellular carcinoma vascular invasion using next-generation sequencing

Qi Li, Qifan Zhang, Jinzhang Chen, Mengya Zang, Xiaoyun Hu, Rong Li, Jinlin Hou, Jie Zhou

Journal of Gastrointestinal Oncology

2022;

(4)

:1864-1874

(31 August 2022)

PDF Full Text (1786) Reporting Checklist Data Sharing Statement COI Form Open Access

CircMMP9 accelerates the progression of hepatocellular carcinoma through the miR-149/CCND2 axis

Xiaolou Li, Jiankai Fang, Guangmin Wei, Ying Chen, Dongliang Li

Journal of Gastrointestinal Oncology

2022;

(4)

:1875-1888

(31 August 2022)

PDF Full Text (1575) Reporting Checklist Data Sharing Statement COI Form Open Access

Development of a novel combined nomogram model integrating Rad-score, age and ECOG to predict the survival of patients with hepatocellular carcinoma treated by transcatheter arterial chemoembolization

Aiai Liu, Bo Liu, Xiaodong Duan, Bo Yang, Yiren Wang, Ping Dong, Ping Zhou

Journal of Gastrointestinal Oncology

2022;

(4)

:1889-1897

(31 August 2022)

PDF Full Text (1649) Reporting Checklist Data Sharing Statement COI Form Open Access

Anti-PD-1 antibodies plus lenvatinib in patients with unresectable hepatocellular carcinoma who progressed on lenvatinib: a retrospective cohort study of real-world patients

Jixue Zou, Peixin Huang, Ningling Ge, Xin Xu, Yanhong Wang, Lan Zhang, Yi Chen

Journal of Gastrointestinal Oncology

2022;

(4)

:1898-1906

(31 August 2022)

PDF Full Text (2080) Reporting Checklist Data Sharing Statement COI Form Open Access

Study on efficacy and safety of transcatheter arterial chemoembolization (TACE) combined with regorafenib and PD-1 antibody versus continued TACE combined with regorafenib in patients with hepatocellular carcinoma after failed second-line treatment with regorafenib

Haochen Wang, Weizhong Xiao, Yanjing Han, Shasha Cao, Zhiyuan Zhang, Guang Chen, Yuefeng Hu, Long Jin

Journal of Gastrointestinal Oncology

2022;

(4)

:1907-1914

(31 August 2022)

PDF Full Text (2027) Reporting Checklist Data Sharing Statement COI Form Open Access

Bioinformatic-based mechanism identification of E2F1-related ceRNA and E2F1 immunoassays in hepatocellular carcinoma

Wenlei Dong, Chao Zhan

Journal of Gastrointestinal Oncology

2022;

(4)

:1915-1926

(31 August 2022)

PDF Full Text (2922) Reporting Checklist COI Form Open Access

A novel biomarker NIFK-AS1 promotes hepatocellular carcinoma cell cycle progression through interaction with SRSF10

Huibin Song, Wenjing Li, Sixuan Guo, Zhentao He, Shi Liu, Yongsheng Duo

Journal of Gastrointestinal Oncology

2022;

(4)

:1927-1941

(31 August 2022)

PDF Full Text (1748) Reporting Checklist Data Sharing Statement COI Form Open Access

Bioinformatics analysis of immune infiltrates and tripartite motif (TRIM) family genes in hepatocellular carcinoma

Jun Cao, Bingbing Su, Rui Peng, Hao Tang, Daoyuan Tu, Yuhong Tang, Jie Zhou, Guoqing Jiang, Shengjie Jin, Qian Wang, Aoqing Wang, Renjie Liu, Qiangwei Deng, Chi Zhang, Dousheng Bai

Journal of Gastrointestinal Oncology

2022;

(4)

:1942-1958

(31 August 2022)

PDF Full Text (3055) Reporting Checklist COI Form Open Access

The role of tumor-infiltrating B cells in the tumor microenvironment of hepatocellular carcinoma and its prognostic value: a bioinformatics analysis

Jixue Zou, Chubin Luo, Haoyang Xin, Tongchun Xue, Xiaoying Xie, Rongxin Chen, Lan Zhang

Journal of Gastrointestinal Oncology

2022;

(4)

:1959-1966

(31 August 2022)

PDF Full Text (2528) Reporting Checklist Data Sharing Statement COI Form Open Access

The efficacy and safety of gemcitabine-based combination therapy vs. gemcitabine alone for the treatment of advanced pancreatic cancer: a systematic review and meta-analysis

Zhaohuan Zhang, Shuling He, Ping Wang, Yibing Zhou

Journal of Gastrointestinal Oncology

2022;

(4)

:1967-1980

(31 August 2022)

PDF Full Text (4441) Reporting Checklist COI Form Open Access

Association between progression-free survival and metal stent patency in patients with advanced pancreatic cancer

Jinwoo Ahn, Dong-Won Ahn, Jaewoo Park, Kwangrok Jung, Jong-Chan Lee, Jin-Hyeok Hwang, Ji Bong Jeong, Jaihwan Kim

Journal of Gastrointestinal Oncology

2022;

(4)

:1981-1988

(31 August 2022)

PDF Full Text (1320) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

A phase II trial of gemcitabine and erlotinib followed by ChemoProton therapy plus capecitabine and oxaliplatin for locally advanced pancreatic cancer

Samrat M. Sanghvi, Alex R. Coffman, Chung-Tsen Hsueh, Joseph Kang, Annie Park, Naveenraj L. Solomon, Carlos A. Garberoglio, Mark E. Reeves, Jerry D. Slater, Gary Y. Yang

Journal of Gastrointestinal Oncology

2022;

(4)

:1989-1996

(31 August 2022)

PDF Full Text (1739) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Clinicopathological prognostic factors for gallbladder carcinoma: a retrospective study

Fátima Ramalhosa, Maria João Amaral, Marco Serôdio, Rui Caetano Oliveira, Paulo Teixeira, Maria Augusta Cipriano, José Guilherme Tralhão

Proteogenomic analysis in an early onset diffuse gastric cancer patient revealed alterations in PIK3R1, TP53, SMAD4 and a potential role of the PI3K-AKT and EGFR pathways: a case report

Miguel Cordova-Delgado, Mauricio P. Pinto, Gonzalo Pizarro, Elard Koch, Cristian Vargas, Mauricio Hernández, Guillermo Nourdin, Pablo Saldivia, Maria Paz Rodriguez Z., Alejandro Berkovits, Patricio Manque, Juvenal A. Rios, Benjamin Garcia-Bloj, Marcelo Garrido

Journal of Gastrointestinal Oncology

2022;

(4)

:2057-2064

(31 August 2022)

PDF Full Text (2550) Reporting Checklist COI Form Open Access